RPTX

RPTX

USD

Repare Therapeutics Inc. Common Shares

$1.780-0.040 (-2.198%)

Precio en Tiempo Real

Healthcare
Biotecnología
Canadá

Gráfico de Precios

Loading Chart...

Métricas Clave

Métricas de Mercado
Fundamentos de la Empresa
Estadísticas de Negociación

Métricas de Mercado

Apertura

$1.820

Máximo

$1.855

Mínimo

$1.780

Volumen

0.15M

Fundamentos de la Empresa

Capitalización de Mercado

76.5M

Industria

Biotecnología

País

Canada

Estadísticas de Negociación

Volumen Promedio

0.13M

Bolsa

NMS

Moneda

USD

Rango de 52 Semanas

Mínimo $0.89Actual $1.780Máximo $4.069

Noticias Relacionadas

Analyst Upgrades

HC Wainwright & Co. Maintains Buy on Repare Therapeutics, Lowers Price Target to $3

HC Wainwright & Co. analyst Robert Burns maintains Repare Therapeutics with a Buy and lowers the price target from $5 to $3.

Ver más
HC Wainwright & Co. Maintains Buy on Repare Therapeutics, Lowers Price Target to $3
Analyst Upgrades

HC Wainwright & Co. Maintains Buy on Repare Therapeutics, Lowers Price Target to $3

HC Wainwright & Co. analyst Robert Burns maintains Repare Therapeutics with a Buy and lowers the price target from $5 to $3.

Ver más
HC Wainwright & Co. Maintains Buy on Repare Therapeutics, Lowers Price Target to $3
BusinessWire

Repare Therapeutics to Present Initial Data from Phase 1 LIONS Clinical Trial at 37th AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

Repare Therapeutics Inc. ("Repare" or the "Company") (NASDAQ:RPTX), a clinical-stage precision oncology company, today announced it will share initial topline safety, tolerability and early efficacy data from the Phase

Ver más
Repare Therapeutics to Present Initial Data from Phase 1 LIONS Clinical Trial at 37th AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

Mantente Actualizado

Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.